Podcast 297: Forget about all that vitamin D testing!!

Clinical Conversations » Podcast Feed by NEJM Group

Jul 28, 202212:59Health

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE . THE USUAL AUDIO FILE IS AVAILABLE BELOW Steven Cummings has co-written a take-no-prisoners editorial in the New England Journal of Medicine. The topic? Vitamin D su...

Related Episodes

Continue listening to more episodes from Clinical Conversations » Podcast Feed.

Podcast 301: Monkeypox — what to look for, how to treat

Aug 19, 2022 - 17:28

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE . This time, we look to New York for guidance on re...

Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer

Aug 11, 2022 - 9:32

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE . We’re back with another interview from this year’...

Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial

Aug 9, 2022 - 14:58

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE . Interim results on overall survival in phase 3 of...

Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2

Aug 2, 2022 - 14:08

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK . In treating most exacerbations of chronic...

Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?

Jul 20, 2022 - 29:38

A VIDEO RECORDING OF THIS ROUNDTABLE IS AVAILABLE CLICK HERE . THE USUAL AUDIO FILE IS AVAILABLE BELOW Yo...

Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?

Jul 6, 2022 - 15:45

CREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe...

Podcast 294: PD-1 blockade in locally advanced rectal cancer

Jun 29, 2022 - 13:08

Locally advanced rectal cancer usually receives a three-part treatment: chemotherapy followed by radiothe...

Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate

Jun 27, 2022 - 11:24

Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified a...